ATE207483T1 - Isatinderivate als acetylcholinesterase- inhibitoren und analgetika - Google Patents

Isatinderivate als acetylcholinesterase- inhibitoren und analgetika

Info

Publication number
ATE207483T1
ATE207483T1 AT97908942T AT97908942T ATE207483T1 AT E207483 T1 ATE207483 T1 AT E207483T1 AT 97908942 T AT97908942 T AT 97908942T AT 97908942 T AT97908942 T AT 97908942T AT E207483 T1 ATE207483 T1 AT E207483T1
Authority
AT
Austria
Prior art keywords
analgesics
acetylcholinesterase inhibitors
isatin derivatives
isatin
derivatives
Prior art date
Application number
AT97908942T
Other languages
English (en)
Inventor
Stephen J Shimshock
Abdul E Mutlib
Susan M Chesson
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE207483T1 publication Critical patent/ATE207483T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT97908942T 1996-04-12 1997-03-07 Isatinderivate als acetylcholinesterase- inhibitoren und analgetika ATE207483T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63187096A 1996-04-12 1996-04-12
PCT/US1997/003598 WO1997038993A1 (en) 1996-04-12 1997-03-07 Isatin derivatives as acetylcholinesterase inhibitors and analgesics

Publications (1)

Publication Number Publication Date
ATE207483T1 true ATE207483T1 (de) 2001-11-15

Family

ID=24533114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97908942T ATE207483T1 (de) 1996-04-12 1997-03-07 Isatinderivate als acetylcholinesterase- inhibitoren und analgetika

Country Status (19)

Country Link
EP (1) EP0892796B1 (de)
JP (1) JP4109718B2 (de)
KR (1) KR20000005379A (de)
CN (1) CN1215399A (de)
AR (1) AR006606A1 (de)
AT (1) ATE207483T1 (de)
BR (1) BR9708655A (de)
CA (1) CA2252039C (de)
DE (1) DE69707659T2 (de)
DK (1) DK0892796T3 (de)
ES (1) ES2165586T3 (de)
GR (1) GR3037006T3 (de)
HU (1) HUP9903473A3 (de)
IL (1) IL126308A0 (de)
NO (1) NO984740L (de)
PT (1) PT892796E (de)
TW (1) TW426678B (de)
WO (1) WO1997038993A1 (de)
ZA (1) ZA972990B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
PL2475428T3 (pl) 2009-09-11 2015-12-31 Probiodrug Ag Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
EP2533645B1 (de) 2010-02-09 2016-07-27 The Johns Hopkins University Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen
KR20120123089A (ko) 2010-02-16 2012-11-07 화이자 인코포레이티드 5-HT₄ 수용체의 부분 효능제인 (R)-4-((4-((4-(테트라히드로푸란-3-일옥시)벤조[d]이속사졸-3-일옥시)메틸)피페리딘-1-일)메틸)테트라히드로-2H-피란-4-올
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
EP2686313B1 (de) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazolderivate als glutaminylcyclase-hemmer
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
US9211288B2 (en) 2012-12-13 2015-12-15 H. Lundbeck A/S Compositions comprising vortioxetine and donepezil
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
US10537552B2 (en) 2015-05-05 2020-01-21 Carafe Drug Innovation, Llc Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers
EA034167B8 (ru) 2015-05-22 2021-04-27 Эйджинбайо, Инк. Фармацевтические композиции леветирацетама пролонгированного высвобождения
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
WO2023081800A1 (en) * 2021-11-05 2023-05-11 The Regents Of The University Of California Alpha-2a adrenergic receptor modulators and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US4994472A (en) * 1989-08-02 1991-02-19 Hoechst-Roussel Pharmaceuticals Incorporated 1-(pyridinylamino)-2-pyrrolidinones as pain relievers
US5296488A (en) * 1989-08-02 1994-03-22 Hoechst-Roussel Pharmaceuticals Inc. Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory

Also Published As

Publication number Publication date
IL126308A0 (en) 1999-05-09
JP4109718B2 (ja) 2008-07-02
EP0892796B1 (de) 2001-10-24
DE69707659T2 (de) 2002-05-08
CN1215399A (zh) 1999-04-28
DK0892796T3 (da) 2001-11-19
EP0892796A1 (de) 1999-01-27
PT892796E (pt) 2002-03-28
DE69707659D1 (de) 2001-11-29
AU2072597A (en) 1997-11-07
ZA972990B (en) 1997-11-03
CA2252039A1 (en) 1997-10-23
NO984740D0 (no) 1998-10-09
NO984740L (no) 1998-10-09
CA2252039C (en) 2002-12-24
ES2165586T3 (es) 2002-03-16
JP2001508400A (ja) 2001-06-26
GR3037006T3 (en) 2002-01-31
KR20000005379A (en) 2000-01-25
BR9708655A (pt) 1999-08-03
HUP9903473A3 (en) 2000-09-28
TW426678B (en) 2001-03-21
AU716997B2 (en) 2000-03-16
AR006606A1 (es) 1999-09-08
WO1997038993A1 (en) 1997-10-23
HUP9903473A2 (hu) 2000-05-28

Similar Documents

Publication Publication Date Title
FI956074A0 (fi) Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia
BR9708655A (pt) Derivados de isatina como inibidores de acetilcolinesterase e analgésicos
DE69723711D1 (de) Aralkyl und aralkyliden heterocyclische lactame und imide
DE69731161D1 (de) Kontroller und erweiterungseinheit dafür
ATE194598T1 (de) In der therapie verwendbare chinolin- und chinazolinverbindungen
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
DE69828963D1 (de) Wirstoffabgabe und gentherapiesystem
DE69738197D1 (de) Azolotriazine und pyrimidine
DE69732084D1 (de) Pulsladeverfahren und ladegerät
HUP9901155A3 (en) Quinazoline derivatives as vegf inhibitors
DE69832657D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69835254D1 (de) Empfangseinrichtungen und Empfangsverfahren
ZA973963B (en) Indole derivatives useful in therapy
DE69903143D1 (de) Chromanon und thiochromanon derivate
DE69725663D1 (de) Abrechnungsverfahren und System
ATE240943T1 (de) Isochinolin derivate als urokinase inhibitoren
BR9708677A (pt) Piperidinas e pirrolidinas
DE50001834D1 (de) Vliesanlage und Betriebsverfahren
DE69708629D1 (de) Alkyloxyamin-substituierte fluorenonderivate und ihre verwendung als proteinkinase-c-inhibitoren
DE59914173D1 (de) Zündanlage und zündsteuerverfahren
DE69715118D1 (de) Baublock und Paneel
ATE228372T1 (de) Hcg und derivate als matrixmetalloprotease- inhibitoren
DK0912553T3 (da) Benzo[g]quinolin-derivater
DE69715979D1 (de) Chinolinderivate und ihre Anwendung
SI0892796T1 (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee